172 related articles for article (PubMed ID: 8349794)
1. Just (don't) do it.
Schooley RT
J Clin Invest; 1993 Aug; 92(2):535. PubMed ID: 8349794
[No Abstract] [Full Text] [Related]
2. HIV-1 step study.
Dalgleish A; Stebbing J
Lancet; 2009 Mar; 373(9666):805; author reply 806. PubMed ID: 19269507
[No Abstract] [Full Text] [Related]
3. AIDS vaccines: back to 'plan A'.
Check E
Nature; 2003 Jun; 423(6943):912-4. PubMed ID: 12827164
[No Abstract] [Full Text] [Related]
4. Candidate AIDS vaccines.
Graham BS; Wright PF
N Engl J Med; 1995 Nov; 333(20):1331-9. PubMed ID: 7566026
[No Abstract] [Full Text] [Related]
5. Vaccine against AIDS?
Lancet; 1994 Feb; 343(8896):493-4. PubMed ID: 7906752
[No Abstract] [Full Text] [Related]
6. Vaccine compromise.
Nature; 1993 Apr; 362(6421):576. PubMed ID: 8464502
[No Abstract] [Full Text] [Related]
7. Therapeutic vaccines for preventing AIDS: their use with HAART.
Hoff R; McNamara J
Lancet; 1999 May; 353(9166):1723-4. PubMed ID: 10347978
[No Abstract] [Full Text] [Related]
8. V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical Trials Network.
Montefiori DC; Graham BS; Zhou J; Zhou J; Bucco RA; Schwartz DH; Cavacini LA; Posner MR
J Clin Invest; 1993 Aug; 92(2):840-7. PubMed ID: 8349820
[TBL] [Abstract][Full Text] [Related]
9. India targets local HIV strain in test of AIDS vaccine.
Jayaraman KS
Nature; 2004 Jan; 427(6971):185. PubMed ID: 14724601
[No Abstract] [Full Text] [Related]
10. Induction of humoral and cell-mediated anti-human immunodeficiency virus (HIV) responses in HIV sero-negative volunteers by immunization with recombinant gp160.
Kovacs JA; Vasudevachari MB; Easter M; Davey RT; Falloon J; Polis MA; Metcalf JA; Salzman N; Baseler M; Smith GE
J Clin Invest; 1993 Aug; 92(2):919-28. PubMed ID: 7688766
[TBL] [Abstract][Full Text] [Related]
11. HIV-1/AIDS vaccine development: are we in the darkness.
Qiu C; Xu JQ
Chin Med J (Engl); 2008 May; 121(10):939-45. PubMed ID: 18706210
[No Abstract] [Full Text] [Related]
12. The rational design of an AIDS vaccine.
Douek DC; Kwong PD; Nabel GJ
Cell; 2006 Feb; 124(4):677-81. PubMed ID: 16497577
[TBL] [Abstract][Full Text] [Related]
13. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and protective efficacy of oligomeric human immunodeficiency virus type 1 gp140.
Earl PL; Sugiura W; Montefiori DC; Broder CC; Lee SA; Wild C; Lifson J; Moss B
J Virol; 2001 Jan; 75(2):645-53. PubMed ID: 11134278
[TBL] [Abstract][Full Text] [Related]
15. Vaccines for control of AIDS--an update.
Sharma KB
Indian J Pediatr; 1994; 61(5):535-43. PubMed ID: 7744454
[No Abstract] [Full Text] [Related]
16. Measuring vaccine-induced HIV neutralization: report of a workshop.
Hanson CV
AIDS Res Hum Retroviruses; 1994 Jun; 10(6):645-8. PubMed ID: 8074928
[No Abstract] [Full Text] [Related]
17. [Promising results with the anti-HIV vaccine].
Katlama C
Presse Med; 2003 Jun; 32(21):964. PubMed ID: 12876523
[No Abstract] [Full Text] [Related]
18. Protection of monkeys vaccinated with vpr- and/or nef-defective simian immunodeficiency virus strain mac/human immunodeficiency virus type 1 chimeric viruses: a potential candidate live-attenuated human AIDS vaccine.
Igarashi T; Ami Y; Yamamoto H; Shibata R; Kuwata T; Mukai R; Shinohara K; Komatsu T; Adachi A; Hayami M
J Gen Virol; 1997 May; 78 ( Pt 5)():985-9. PubMed ID: 9152414
[TBL] [Abstract][Full Text] [Related]
19. Oral administration of recombinant adeno-associated virus elicits human immunodeficiency virus-specific immune responses.
Xin KQ; Ooki T; Mizukami H; Hamajima K; Okudela K; Hashimoto K; Kojima Y; Jounai N; Kumamoto Y; Sasaki S; Klinman D; Ozawa K; Okuda K
Hum Gene Ther; 2002 Sep; 13(13):1571-81. PubMed ID: 12228012
[TBL] [Abstract][Full Text] [Related]
20. Hope in a vial. Will there be an AIDS vaccine anytime soon?
Ezzell C
Sci Am; 2002 Jun; 286(6):38-45. PubMed ID: 12030090
[No Abstract] [Full Text] [Related]
[Next] [New Search]
